Retina Synthesis

Retina Synthesis
  • 4,5 (8)
  • ÉDUCATION
  • CHAQUE SEMAINE
Retina Synthesis

Retina Synthesis is a data-focused resource exploring therapies in development for retinal diseases.

  1. 12 JUIL.

    Eyes with both Geographic Atrophy and Neovascular AMD: An IRIS Study

    We discuss management of eyes with both geographic atrophy and neovascular AMD with Dr. Ted Leng of the Byers Eye Institute, Stanford University School of Medicine

    12 min

  2. 31 MAI

    The Davio 2 Trial for Neovascular AMD

    We review the 6 month results of the Davio 2 trial of the Durayvu TKI delivery system for maintenance therapy of neovascular AMD with Dr. Carl Regillo of Wills Eye Hospital.

    14 min

  3. 17 MAI

    The GALE Extension Study

    We discuss the latest promising results from the GALE extension study of pegcetacoplan with Dr. Ashkan Abbey of Texas Retina Associates

    15 min

  4. 9 MAI

    AXPAXLI for Diabetic Retinopathy

    We discuss the promising phase I results of the Helios trial studying AXPAXLI TKI inhibitor implant for diabetic retinopathy with Dr. Dilsher Dhoot of California Retina Consultants.

    5 min

  5. 18 AVR.

    NSAIDS in the treatment of Central Serous Chorioretinopathy

    We discuss the use of non steroidal inflammatory agents in the management of central serous chorioretinopathy with Dr. Michael Singer of San Antonio, Texas

    14 min

  6. 4 AVR.

    EY-103 a novel Wnt Pathway Agonist for Treatment of DME and neovascular AMD

    We discuss remarkable preliminary results from the the use of intravitreal EYE-103, a novel Wnt pathway agonist in the treatment of DME and neovascular AMD with Dr. Charles Wykoff of Houston Texas.

    22 min

  7. 28 MARS

    Intravitreal Gene Therapy for neovascular AMD with 4D-150

    We discuss the first interim results of a novel intravitreal gene therapy agent, 4D-150, with Dr. Arshad Khanani of Sierra Eye Associates and the University of Nevada Reno School of Medicine.

    14 min

  8. 21 MARS

    KSI 501 Bispecific Anti-VEGF Biopolymer Treatment of DME

    We discuss the use of a novel bispecific anti-VEGF Anti IL-6 Antibody Biopolymar Conjugate for the treatment of DME with Dr. Mark R. Barakat of Phoenix, AZ.

    8 min
Tout afficher (147)

Notes et avis

4,5
sur 5
8 notes

À propos

Retina Synthesis is a data-focused resource exploring therapies in development for retinal diseases.

Informations

  • Création
    Retina Synthesis
  • Années d’activité
    2021 - 2024
  • Épisodes
    147
  • Classification
    Tous publics
  • Copyright
    © 2024 Retina Synthesis
  • Site web de l’émission
    Retina Synthesis

Vous aimeriez peut‑être aussi

Pour écouter des épisodes au contenu explicite, connectez‑vous.

Recevez les dernières actualités sur cette émission

Connectez‑vous ou inscrivez‑vous pour suivre des émissions, enregistrer des épisodes et recevoir les dernières actualités.
Choisissez un pays ou une région

Afrique, Moyen‑Orient et Inde

Asie‑Pacifique

Europe

Amérique latine et Caraïbes

États‑Unis et Canada